The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients
NCT ID: NCT01862185
Last Updated: 2014-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
205 participants
INTERVENTIONAL
2012-12-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of the study are :
* There is an effect on mortality between septic patients who do and do not do semi-quantitative PCT examination
* There is an effect on empirical antibiotic initiation time between septic patients who do and do not do semi-quantitative PCT examination
* There is an effect on appropriateness of empirical antibiotic between septic patients who do and do not do semi-quantitative PCT examination
Study design is randomized diagnostic trial which is also a pragmatic trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PCT Guided Antibiotics Use in Critically Ill Adult Patients in China
NCT06945510
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304
Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection
NCT01025180
Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU
NCT06395454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
semi-quantitative procalcitonin
patients whom checked semi-quantitative procalcitonin examination
semi-quantitative procalcitonin
control
patients whom do not checked semi-quantitative procalcitonin examination
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
semi-quantitative procalcitonin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have at least two concomitant systemic inflammatory response syndrome criteria
* have focal infection
* with or without sign of organ hypoperfusion or dysfunction
Exclusion Criteria
* trauma patient
* have obtained prior antibiotic
* refused to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dana Dharaniyadewi
student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dana Dharaniyadewi, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AB-PCTQ1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.